Merus (NASDAQ:MRUS) Coverage Initiated at Piper Sandler
Equities researchers at Piper Sandler assumed coverage on shares of Merus (NASDAQ:MRUS – Get Free Report) in a report issued on Thursday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $84.00 price target on the biotechnology company’s stock. Piper Sandler’s price objective would indicate a potential upside of 108.96% from the stock’s […]
Equities researchers at Piper Sandler assumed coverage on shares of Merus (NASDAQ:MRUS – Get Free Report) in a report issued on Thursday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $84.00 price target on the biotechnology company’s stock. Piper Sandler’s price objective would indicate a potential upside of 108.96% from the stock’s […]
